Vir Biotechnology, Inc. (VIR)
7.56
-0.26
(-3.32%)
USD |
NASDAQ |
Feb 20, 16:00
7.565
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Profit Margin (Quarterly) : -67.98K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 20.83% |
| Merck & Co., Inc. | 18.06% |
| Eton Pharmaceuticals, Inc. | -8.58% |
| Sensei Biotherapeutics, Inc. | -- |
| Moderna, Inc. | -121.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.24% |
| Return on Assets | -38.78% |
| Return on Invested Capital | -43.92% |
| Gross Profit Margin (Quarterly) | -1.14K% |
| Operating Margin (Quarterly) | -72.03K% |
| Return on Net Operating Assets | -332.2% |